1.Feb 25, 2013: Mr. Yogi Hsuan, Chairman of Meridigen and the son of the Emeritus Vice Chairman of UMC (United Microelectronics Corp.), John Hsuan announced today that Meridigen has licensed in the Anti-CD3 Collabody (an anti-CD3 collagen scaffold antibody) from Industrial Technology and Research Institute (ITRI).
Yogi Hsuan, Chairman of Meridigen stated that there are more than 10 biotechnology and pharmaceutical companies had expressed interests to get involved in the building of the Biomedical Park. (Economic Daily News)
Chairman of the Board: Yogi Hsuan, ???Mr. Yogi Hsuan graduated from Shanghai Jiao Tong University (Master of medicine), he is an experienced practicing physician and acupuncturist, as well as an expert in hair follicle stem cell, traditional Chinese medicine and Western medicine.
In 2011, Mr. Hsuan started Vital First, a financial management company with the objectives to support start-up biotechnology innovative projects from academic and research institutions, as well as industrial sectors, with good potential to be quickly transformed into commercially viable products for the welfare of mankind.Vital First has formed strategic alliance with other VC groups in Taiwan, such as BioFirst Biomedical Group, Fortune Venture Investment Group, and Shin Kong Capital Management (SKCM).
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.